首页> 外文期刊>Scandinavian journal of infectious diseases. >Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.
【24h】

Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.

机译:南太平洋新喀里多尼亚一家三级医院的耐碳青霉烯类鲍曼不动杆菌感染的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

In New Caledonia, South Pacific, Acinetobacter baumannii is a nosocomial pathogen. OXA-23 carbapenem-resistant A. baumannii (CRAB) has been ranked third among all multidrug-resistant (MDR) bacteria at the main hospital of Noumea in New Caledonia (24.8%, 50/202 isolates). In the present study, risk factors and outcomes for 50 patients with CRAB infection were compared with those of 152 patients infected with other MDR bacteria. Independent risk factors for infection with CRAB were respiratory ward admission (odds ratio 2.8, 95% confidence interval 1.1-7.1) and previous treatment with quinolones, beta-lactams and anti-MRSA antibiotics. The 30-day mortality was higher for CRAB infections compared with other MDR infections (14% vs 3.3%, p = 0.006). These findings highlight the importance of knowing specific local characteristics relating to the ecology and patterns of resistance of MDR bacteria so as to avoid the emergence of unexpected pan-resistant bacteria.
机译:在南太平洋的新喀里多尼亚,鲍曼不动杆菌是医院内病原体。 OXA-23耐碳青霉烯鲍曼不动杆菌(CRAB)在新喀里多尼亚努美阿主医院的所有多药耐药(MDR)细菌中排名第三(24.8%,50/202分离株)。在本研究中,将50例CRAB感染患者和152例其他MDR细菌感染患者的危险因素和结果进行了比较。感染CRAB的独立危险因素是呼吸系统病房入院(优势比2.8,95%置信区间1.1-7.1)以及先前使用喹诺酮类,β-内酰胺类和抗MRSA抗生素治疗。与其他MDR感染相比,CRAB感染的30天死亡率更高(14%比3.3%,p = 0.006)。这些发现强调了了解与MDR细菌的生态和耐药模式有关的特定局部特征的重要性,以避免出现意料之外的泛耐药细菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号